Keros Therapeutics director Newton sells shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Keros Therapeutics, Inc. director Charles W. Newton reported direct common-stock sales on November 17, 2026: Charles W. Newton sold 491 shares at a weighted average price of $10.83 and sold 60 shares at a weighted average price of $11.05. The sales were made under a Rule 10b5-1 trading plan adopted March 12, 2026.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock F1, F2 | 491 | $10.83 | $5K |
| Sale | Common Stock F1, F3 | 60 | $11.05 | $663.00 |
Footnotes (3)
- F1. The transactions were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026.
- F2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.02 to $11.01 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.04 to $11.06 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Key Figures
Key Terms
Rule 10b5-1 trading plan regulatory
weighted average price financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What were the KROS sale price ranges for Charles W. Newton’s November 17, 2026 sales?
AI-generated analysis. How Rhea-AI works. Not financial advice.